Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2019 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
At month 12, the decline in the 6-minute walk distance was lower in the patisiran group than in the placebo group (Hodges-Lehmann estimate of median difference, 14.69 m; 95% confidence interval [CI], 0.69 to 28.69; P = 0.02); the KCCQ-OS score increased in the patisiran gr …
At month 12, the decline in the 6-minute walk distance was lower in the patisiran group than in the placebo group (Hodges-Lehmann estimate o …
Concurrent of blaCTX-M and blaNDM-1 genes in clinical isolates of Escherichia coli from northern Iran.
Shahandeh Z, Kalantari N, Sadighian F, Aram H, Etminan M. Shahandeh Z, et al. Trop Biomed. 2019 Jun 1;36(2):459-467. Trop Biomed. 2019. PMID: 33597407 Free article.
The present study aimed to evaluate the existence of blaCTX-M, blaTEM, blaSHV, blaNDM-1 and blaIMP1 genes among E. coli isolated from patients in Babol, Northern Iran. ...Of 259 isolates, 117 beta-lactamase producing E.coli were detected. MDR isolates were ob …
The present study aimed to evaluate the existence of blaCTX-M, blaTEM, blaSHV, blaNDM-1 and blaIMP1 genes among E. coli isolat …
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
Dodaran MS, Banihashemi SR, Es-Haghi A, Mehrabadi MHF, Nofeli M, Mokarram AR, Mokhberalsafa L, Sadeghi F, Ranjbar A, Ansarifar A, Mohazzab A, Setarehdan SA, Bagheri Amiri F, Mohseni V, Hajimoradi M, Ghahremanzadeh N, Razzaz SH, Masoomi S, Taghdiri M, Bagheri M, Lofti M, Khorasani A, Ghader M, Safari S, Shahsavn M, Kalantari S. Dodaran MS, et al. Vaccines (Basel). 2023 Feb 16;11(2):455. doi: 10.3390/vaccines11020455. Vaccines (Basel). 2023. PMID: 36851334 Free PMC article.
Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.
Tafakori Delbari M, Cheraghi T, Yazdani R, Fekrvand S, Delavari S, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Ahanchian H, Khoshkhui M, Behmanesh F, Aleyasin S, Esmaeilzadeh H, Jabbari-Azad F, Fallahpour M, Zamani M, Madani SP, Moazzami B, Habibi S, Rezaei A, Lotfalikhani A, Movahed M, Shariat M, Kalantari A, Babaei D, Darabi M, Parvaneh N, Rezaei N, Abolhassani H, Aghamohammadi A. Tafakori Delbari M, et al. Int Arch Allergy Immunol. 2019;180(1):52-63. doi: 10.1159/000500197. Epub 2019 May 22. Int Arch Allergy Immunol. 2019. PMID: 31117086
BACKGROUND: Hyper-immunoglobulin M (HIGM) syndrome is a rare heterogeneous group of primary immunodeficiency disorders characterized by low or absent serum levels of IgG and IgA along with normal or elevated serum levels of IgM. ...
BACKGROUND: Hyper-immunoglobulin M (HIGM) syndrome is a rare heterogeneous group of primary immunodeficiency disorders characterized …
The effect of pregnancy on the response to blood loss in a rat model.
Sinert R, Baron BJ, Ko CT, Zehtabchi S, Kalantari HT, Sapan A, Patel MR, Silverberg M, Stavile KL. Sinert R, et al. Resuscitation. 2001 Aug;50(2):217-26. doi: 10.1016/s0300-9572(01)00348-3. Resuscitation. 2001. PMID: 11719150
Mean arterial pressure (MAP) and base excess (BE) were measured pre-hemorrhage and then every 15 min post-hemorrhage for the next 90 min. Data were reported as mean+/-standard error of the mean (S.E.M.) over the 90-min post-hemorrhage observation period. Group compa …
Mean arterial pressure (MAP) and base excess (BE) were measured pre-hemorrhage and then every 15 min post-hemorrhage for the next 90 min. Da …